passages.id: 150
passages.type: sentence
passages.text: This study was conducted to determine the long-term effect of flosequinan , a new orally administered arterial and venous dilator , on the clinical course of patients with moderate to severe congestive heart failure .
entities.id: 151
entities.type: intervention
entities.text: flosequinan
entities.id: 152
entities.type: outcome
entities.text: long-term effect
entities.id: 153
entities.type: outcome
entities.text: clinical course
entities.id: 154
entities.type: participant
entities.text: patients with moderate to severe congestive heart failure